Senate Opioids Bill Would Add Sunshine Provisions, Expand Medicare Telehealth Services
Senators on June 12 advanced a bill addressing the opioid crisis from the Finance Committee, including sunshine provisions expanding the types of providers that must report payments of value by drug and device manufacturers, requiring an essential Medicare handbook to describe non-opioid alternatives for pain control, and expanding telehealth payments for providers treating beneficiaries with substance use disorders.
You may also be interested in...
Bills Supporting Device Opioid Alternatives Advance In House
The House Energy and Commerce Committee approved four opioid crisis-related bills that call for US FDA meetings and consideration of streamlined pathways for medtech alternatives to opioids, and for a report and action by the US Medicare agency on overcoming payment challenges to device pain control products.
Bills Advancing In US Congress Would Hasten FDA Reviews Of Non-Opioid Medtech Alternatives
The Senate Health, Education, Labor and Pensions (HELP) Committee and House Energy and Commerce Health Subcommittee each passed bills this week to expedite approval pathways for non-opioid devices and drugs to control pain and prevent further addictions. Other opioid bills passed by the House subpanel seek to remove reimbursement challenges for opioid-alternative pain control devices.
Medtech Provisions Approved In US Budget Agreement
Medtech and funding provisions in a two-year budget deal that the US Senate and House approved early Friday morning and which were signed by the President would extend Medicate telehealth programs, remove a rental cap for speech-generating devices and strengthen competitive bidding rules to assure access to diabetic test strips, among others.